Invention Grant
- Patent Title: Pharmaceutical formulation for histone deacetylase inhibitors
- Patent Title (中): 组蛋白脱乙酰酶抑制剂的药物制剂
-
Application No.: US13878994Application Date: 2011-10-13
-
Publication No.: US09255066B2Publication Date: 2016-02-09
- Inventor: Todd W. Chappell , Keith A. Johnson
- Applicant: Todd W. Chappell , Keith A. Johnson
- Applicant Address: GB Birmingham
- Assignee: TetraLogic Shape UK Ltd
- Current Assignee: TetraLogic Shape UK Ltd
- Current Assignee Address: GB Birmingham
- Agency: Banner & Witcoff, Ltd.
- International Application: PCT/US2011/056148 WO 20111013
- International Announcement: WO2012/051416 WO 20120419
- Main IPC: C07C259/06
- IPC: C07C259/06 ; A61K9/00 ; A61K9/06 ; A61K31/165 ; A61K31/222 ; A61K47/02 ; A61K47/10 ; A61K47/12 ; A61K47/14 ; A61K47/38
Abstract:
A pharmaceutical composition, comprising a therapeutically effective amount of an active pharmaceutical ingredient (API) compound represented by the following structural formula at least one acidifying agent; and a vehicle base comprising at least one pharmaceutically acceptable non-aqueous solvent. Values and preferred values of the variables in structural formula (I) are defined herein.
Public/Granted literature
- US20130203847A1 Pharmaceutical Formulation for Histone Deacetylase Inhibitors Public/Granted day:2013-08-08
Information query
